Lubor Gaal
Director of Finance/CFO at CIRCIO HOLDING ASA
Net worth: 1 $ as of 30/03/2024
Profile
Lubor Gaal is currently an Independent Director at Trex Wind-down, Inc. and the Chief Financial Officer at Circio Holding ASA. Previously, he worked at Bristol Myers Squibb Co. as the Head of Neuroscience, Immunoscience & Fibrosis from 2006 to 2015.
He also held positions at Bayer AG as the Head of CNS & CV Licensing, Almirall SA as the Head of External Innovation & Licensing, Neuro3D SA as the Head of Sales & Marketing, and Locust Walk Partners LLC as the Senior Vice President & Head of Europe.
Dr. Gaal obtained his undergraduate degree from the University of Sussex and his doctorate degree from the University of California.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
TREX WIND DOWN INC
0.10% | 06/09/2023 | 3,366 ( 0.10% ) | 1 $ | 30/03/2024 |
Lubor Gaal active positions
Companies | Position | Start |
---|---|---|
TREX WIND-DOWN, INC. | Director/Board Member | 18/08/2020 |
CIRCIO HOLDING ASA | Director of Finance/CFO | 06/03/2022 |
Former positions of Lubor Gaal
Companies | Position | End |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/2014 |
BAYER AG | Corporate Officer/Principal | - |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
ALMIRALL, S.A. | Corporate Officer/Principal | - |
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Sales & Marketing | - |
Training of Lubor Gaal
University of Sussex | Undergraduate Degree |
University of California | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BAYER AG | Health Technology |
ALMIRALL, S.A. | Health Technology |
CIRCIO HOLDING ASA | Health Technology |
TREX WIND-DOWN, INC. | Health Technology |
Private companies | 2 |
---|---|
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Health Technology |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Commercial Services |
- Stock Market
- Insiders
- Lubor Gaal